Immune Defense Mechanisms at the Mucosa Cooperative Study Group (U01)

The summary for the Immune Defense Mechanisms at the Mucosa Cooperative Study Group (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Immune Defense Mechanisms at the Mucosa Cooperative Study Group (U01): Purpose. The National Institute of Allergy and Infectious Diseases (NIAID) invites applications from institutions/organizations to participate in a cooperative study group focused on immune defense mechanisms and immune regulation at mucosal surfaces including respiratory, gastrointestinal and urogenital tract mucosa. The goal is to break new ground in the understanding of basic mucosal immune defense mechanisms by introducing new ideas, approaches and technologies that address the difficult questions remaining in mucosal immune defense. The knowledge gained would facilitate future development of vaccines and immunotherapies to protect mucosal surfaces from infection and related immunopathologies. The cooperative study group will be composed of a set of cooperative agreement grants governed by a Steering Committee, and will draw upon an Infrastructure and Opportunities Fund to support a range of innovative, collaborative, and pilot/feasibility projects. NIAID encourages submissions from established and new investigators; applicants without a prior track record of funding in mucosal immunity are welcome to apply. Mechanism of Support. This FOA will utilize the cooperative agreement (U01) award mechanism. Funds Available and Anticipated Number of Awards. For this funding opportunity, budgets up to $250,000 direct costs per year and time periods up to five years may be requested. NIAID expects to allocate approximately $4 million in total costs in FY 2011 to fund seven to nine awards.

Federal Grant Title:	Immune Defense Mechanisms at the Mucosa Cooperative Study Group (U01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-AI-10-008
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.855
CFDA Descriptions:	Allergy, Immunology and Transplantation Research
Current Application Deadline:	Oct 22, 2010
Original Application Deadline:	Oct 22, 2010
Posted Date:	Apr 23, 2010
Creation Date:	Apr 23, 2010
Archive Date:	Nov 22, 2010
Total Program Funding:	$4,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Immune Tolerance Network (UM1 Clinical Trial Required); • Accelerating Research and Development of Next Generation Vaccines against Malaria - a Mode...; • Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required); • Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required); • Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional); • Center for HIV/AIDS Vaccine Immunology (CHAVI); • Genomics of Transplantation Cooperative Research Program; • Asthma and Allergic Diseases Cooperative Research Centers
More Grants from the National Institutes of Health: • NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices ...; • Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinic...; • Immune Tolerance Network (UM1 Clinical Trial Required); • Coordinating Center for National Resource Network for the Study of Human Auditory and Vest...; • National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Cl...